ISIS 443139

ISIS-443139 · Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISIS 443139, covering 2019-05-31 to 2019-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISIS 443139 in Participants With Early Manifest Huntington's Disease [Phase 1, Phase 2]

See pricing